These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 4371345

  • 1. Dissociation of growth hormone and prolactin secretion in Parkinson's disease following chronic L-dopa therapy.
    Malarkey WB, Cyrus J, Paulson GW.
    J Clin Endocrinol Metab; 1974 Aug; 39(2):229-35. PubMed ID: 4371345
    [No Abstract] [Full Text] [Related]

  • 2. Stimulation of human-growth-hormone secretion by L-dopa.
    Boyd AE, Lebovitz HE, Pfeiffer JB.
    N Engl J Med; 1970 Dec 24; 283(26):1425-9. PubMed ID: 5481776
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Amantadine enhancement of L-DOPA induced growth hormone stimulation.
    Massara F, Camanni F, Molinatti GM.
    Horm Metab Res; 1973 Nov 24; 5(6):454-6. PubMed ID: 4767002
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The influence of levodopa and adrenergic blockade on growth hormone and prolactin secretion in the MStTW15 tumor bearing rat.
    Malarkey WB, Daughaday WH.
    Endocrinology; 1972 Nov 24; 91(5):1314-7. PubMed ID: 4403699
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Functional evaluation of prolactin secretion: a guide to therapy.
    Friesen H, Guyda H, Hwang P, Tyson JE, Barbeau A.
    J Clin Invest; 1972 Mar 24; 51(3):706-9. PubMed ID: 4622109
    [Abstract] [Full Text] [Related]

  • 14. Effect of dopamine agonist (Lergotrile mesylate) therapy on twenty-four hour secretion of prolactin in treated Parkinson's disease.
    Bell RD, Carruth A, Rosenberg RN, Boyar RM.
    J Clin Endocrinol Metab; 1978 Oct 24; 47(4):807-11. PubMed ID: 45469
    [Abstract] [Full Text] [Related]

  • 15. [Treatment of Parkinson's syndrome with L-dopa].
    Ljung O.
    Lakartidningen; 1972 Jun 07; 69(24):2940-4. PubMed ID: 5037135
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Clinical study of L-dopa in Parkinson's disease].
    Franken L, Noel G, Lhoas JP, Meyers C, Noel P, Ectors M.
    Brux Med; 1972 Dec 07; 52(12):851-60. PubMed ID: 4575350
    [No Abstract] [Full Text] [Related]

  • 18. [Personal experience in the treatment of Parkinson's disease with L-Dopa].
    Figuerido JA, De la Herrán J.
    Rev Clin Esp; 1970 Dec 31; 119(6):555-62. PubMed ID: 5509794
    [No Abstract] [Full Text] [Related]

  • 19. [Dopaminergic control of the diencephalo-pituitary axis for somatotropin secretion].
    Cavagnini F, Pontiroli AE, Raggi U, Peracchi M, Malinverni A.
    Folia Endocrinol; 1973 Dec 31; 26(6):483-9. PubMed ID: 4801258
    [No Abstract] [Full Text] [Related]

  • 20. Bensarazid with L-dopa in the treatment of parkinson's disease.
    Van Wieringen A.
    S Afr Med J; 1974 Feb 09; 48(6):206-9. PubMed ID: 4814495
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.